Flexible Solutions International Inc: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 15, 2026 and accepted by EDGAR at May 15, 2026, 20:00 ET.
Management's discussion and analysis
As filed, 6,125 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview
The Company manufactures and markets biodegradable polymers which are used in the oil, gas and agriculture industries. The Company also develops, manufactures and markets specialty chemicals that slow the evaporation of water.
Results of Operations
The first is a chemical (“EWCP”) used in swimming pools and spas. The product forms a thin, transparent layer on the water’s surface. The transparent layer slows the evaporation of water, allowing the water to retain a higher temperature for a longer period of time thereby reducing the energy required to maintain the desired temperature of the water. A modified version of EWCP can also be used in reservoirs, potable water storage tanks, livestock watering pods, canals, and irrigation ditches for the purpose of reducing evaporation.
The second product, biodegradable polymers (“TPAs”), is used by the petroleum, chemical, utility and mining industries to prevent corrosion and scaling in water piping. TPAs can also be used to increase biodegradability in detergents and in the agriculture industry to increase crop yields by enhancing fertilizer uptake.
The third product line is nitrogen conservation products used for the agriculture industry. These products decrease the loss of nitrogen fertilizer after initial application and allows less fertilizer to be used. These products are made and sold by the Company’s TPA division.
The Company also manufactures food grade products that are made and sold by the TPA division.
Material changes in the Company’s Statement of Operations for three months ended March 31, 2026 compared to the same period in the prior year are discussed below:
Three Months ended March 31, 2026
| Item | Increase (I) or Decrease (D) | Reason |
| Sales | ||
| EWCP products | I | Increased customer orders. |
| TPA products | I | Increased customer orders. |
| Gross profit as a percentage of sales | D | Increased costs associated with scaling up new products and a new manufacturing location along with an increase in sales of lower margins products in 2026 over 2025. |
| Professional fees | D | Q1 2025 included audit fees relative to the 2024 audit that were underaccrued. |
| Wages, administrative salaries and benefits | I | Increase in employees in the TPA division. |
| Income on investment | D | The investee in which the Company applies the equity method, had a net loss for the period as opposed to net income as in prior year. |
| Interest expense | D | Decreased debt resulted in decreased interest expense. |
| Interest income | D | Decrease in term deposits held. |
| Income tax expense | D | The BPCA division recorded an operating loss in Q1 2026 which resulted in lower income taxes assessed than what was recorded in Q1 2025. |
19
Three primary customers accounted for 56% of the Company’s sales during the three months ended March 31, 2026 (2025 - 49%). The amount of revenue (all from the sale of TPA products) attributable to each customer is shown below.
| Three Months Ended March 31, 2026 | 2025 | |||
|---|---|---|---|---|
| Company A | $895,953 | $830,483 | ||
| Company B | $498,418 | * | $1,856,395 | |
| Company C | $1,163,662 | $978,357 | ||
| Company D | $2,579,509 | $- | * |
*not a primary customer in that period
Customers with balances greater than 10% of our receivables as of March 31, 2026 and December 31, 2025 are shown below:
| March 31, 2026 | December 31, 2025 | ||
|---|---|---|---|
| Company A | $7,554,641 | $6,652,611 | |
| Company D | $1,015,838 | * | $1,866,972 |
*less than 10% at period end
Other factors that will most significantly affect future operating results will be:
- the sale price of crude oil which is used in the manufacture of aspartic acid we import from China. Aspartic acid is a key ingredient in our TPA products;
- activity in the oil and gas industry, as we sell our TPA products to oil and gas companies;
- drought conditions, since we also sell our TPA products to farmers; and
- new tariffs relating to raw materials imported from China.
Other than the foregoing we do not know of any trends, events or uncertainties that have had, or are reasonably expected to have, a material impact on our revenues or expenses.
Capital Resources and Liquidity
The Company’s sources and (uses) of cash for the three months ended March 31, 2026 and 2025 are shown below:
| 2026 | 2025 | |
|---|---|---|
| Cash used in operating activities | (1,818,177) | (544,294) |
| Maturities of term deposits | 733,340 | 1,019,760 |
| Purchase of property, equipment and leaseholds | (2,233,765) | (354,121) |
| Proceeds of short-term lines of credit, net | 2,648,058 | 1,938,670 |
| Repayment of long term debt | (101,636) | (616,343) |
| Distributions to non-controlling interest | (68,659) | - |
| Distribution received upon dissolution of subsidiary | 72,953 | - |
| Proceeds from shares issued upon exercise of stock options | 50,200 | 381,690 |
| Effect of exchange rate changes on cash | (86,283) | 188,840 |
The Company has sufficient cash resources to meets its future commitments and cash flow requirements for the coming year. As of March 31, 2026, working capital was $20,878,345 (December 31, 2025 - $22,173,434) and the Company has no substantial commitments that require significant outlays of cash over the coming fiscal year.
The Company does not anticipate any capital requirements for the twelve months ending March 31, 2027.
We do not know of any trends, demands, commitments, events or uncertainties that will result in, or that are reasonable likely to result in, our liquidity increasing or decreasing in any material way.
Other than as disclosed above, we do not know of any significant changes in our expected sources and uses of cash.
We do not have any commitments or arrangements from any person to provide us with any equity capital.
There have been no significant changes to the critical accounting estimates disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2025 Form 10-K.
Controls and procedures
As filed, 1,925 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Under the direction and with the participation of our management, including our Principal Executive and Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2026. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports with the Securities and Exchange Commission is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and regulations, and that such information is accumulated and communicated to our management, including our principal executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls and procedures are designed to provide a reasonable level of assurance of reaching desired disclosure control objectives. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were ineffective. In 2026, the Company will implement new procedures to improve its disclosure controls and procedures.
Changes in Internal Control over Financial Reporting
At December 31, 2025, management identified material weaknesses in our internal control over financial reporting (“ICFR”) related to a material adjustment identified during the audit process indicating that controls over the financial statement close and review process were not operating effectively to prevent or detect misstatements on a timely basis. Because of the material weaknesses described above, we implemented new procedures to improve our financial statement close and review process during the quarter ended March 31, 2026. Remediation is in progress and is anticipated to be fully in place by the fourth quarter of 2026.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $8.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $6.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-01-01 to 2026-03-31 | $1.9m | us-gaap:GrossProfit |
| Research and development | 3 months2026-01-01 to 2026-03-31 | $116.5k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2026-01-01 to 2026-03-31 | $762.4k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-01-01 to 2026-03-31 | −$86.0k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2026-01-01 to 2026-03-31 | −$241.4k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 12,735,609 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2026-01-01 to 2026-03-31 | −$1.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2026-01-01 to 2026-03-31 | $2.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2026-03-31 | $5.8m | us-gaap:Cash |
| Current assets | At period end2026-03-31 | $34.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $63.9m | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $13.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $21.3m | us-gaap:Liabilities |
| Long-term debt | At period end2026-03-31 | $3.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2026-03-31 | $414.2k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2026-03-31 | $38.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-26-023701. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.